Tempus ECG-Low EF vs CVI42

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Tempus
VS
by Circle Cardiovascular Imaging Inc.

AI Verdict

Tempus ECG-Low EF is an AI tool specifically designed for early detection of low left ventricular ejection fraction using ECG recordings. In contrast, CVI42 is a broader AI-enabled platform for comprehensive cardiac and vascular imaging analysis utilizing CT and MRI data. While both serve cardiology, they address distinct diagnostic needs and leverage different input modalities within the patient care pathway.

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your primary goal is rapid, AI-powered screening for signs of low left ventricular ejection fraction (LVEF ≤40%) using standard 12-lead ECGs. This tool is ideal for identifying patients 40 years or older at risk of heart failure who may require further diagnostic evaluation, particularly in high-volume clinical settings like emergency departments or primary care where quick triage is essential.

View Tempus ECG-Low EF →

Choose CVI42 if…

Choose CVI42 if you require comprehensive, AI-enabled analysis of advanced cardiac and vascular imaging studies (CT and MRI) for detailed diagnosis, treatment planning, and patient care. This platform is best suited for specialized cardiology, cardiothoracic surgery, and radiology departments needing in-depth quantification of coronary plaque, advanced CMR automation, and 3D visualization for complex cases.

View CVI42 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Tempus ECG-Low EF CVI42
Pricing Unknown Starts at $5,000 per license.
Deployment Integrates with current ECG platforms and electronic health records (EHRs). On-premise (standalone workstation or client/server)
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tempus ECG-Low EF

Tempus ECG-Low EF (Tool A) offers a straightforward, binary output (Low LVEF Detected / Not Detected) and is designed for integration into existing healthcare facility workflows, suggesting a simpler user experience for a specific screening task. CVI42 (Tool B), while powerful, is a comprehensive platform for advanced imaging analysis, implying a steeper learning curve due to its extensive features and 3D visualization capabilities.

Clinical Value

Tie

Both tools offer significant clinical value in different aspects of cardiovascular care. Tempus ECG-Low EF (Tool A) provides FDA-cleared AI analysis of ECGs for early detection of low LVEF, addressing a broad screening need for heart failure risk. CVI42 (Tool B) offers comprehensive, advanced diagnostic and planning tools for complex cardiac and vascular conditions using CT and MRI, providing deep insights for specialized cases.

Pricing & Value

CVI42

While both tools require direct vendor contact for pricing, CVI42 (Tool B) offers more transparency by detailing a 'Flexible subscription that scales across CT and MR service lines' with additional licenses for specific modules. This provides a clearer understanding of its pricing model and potential scalability compared to Tempus ECG-Low EF's (Tool A) general 'contact vendor' statement.

Enterprise Readiness

Tempus ECG-Low EF

Tempus ECG-Low EF (Tool A) explicitly states it is HIPAA compliant, offers a Business Associate Agreement (BAA), and has FDA clearance, along with deployment integrated into healthcare workflows. CVI42 (Tool B) does not disclose BAA or HIPAA compliance in the provided facts, which is a critical factor for enterprise adoption in healthcare, despite having FDA clearance and DICOM/HL7 compatibility.

Innovation

CVI42

While Tempus ECG-Low EF (Tool A) is innovative in applying AI to ECGs for LVEF detection, trained on a large dataset, CVI42 (Tool B) demonstrates a broader and deeper range of advanced AI applications across multiple complex imaging modalities. Its features include AI-automated coronary lumen and wall segmentation, comprehensive plaque analysis, advanced CMR automation, and research-use features like Pericoronary Adipose Tissue (PCAT) analysis.

Support & Docs

CVI42

CVI42 (Tool B) provides extensive technical documentation, including user manuals for various software versions, installation guides, and DICOM/HL7 conformance statements. Furthermore, customer testimonials and satisfaction scores highlight its strong customer support. Tempus ECG-Low EF (Tool A) offers customer support via email and phone, but the level of detail regarding comprehensive documentation and explicit satisfaction metrics is less prominent in the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Tempus ECG-Low EF CVI42
Name Tempus ECG-Low EF CVI42
Company Tempus AI CIRCLE CARDIOVASCULAR IMAGING
Description FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. AI-enabled software platform for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools.
Key Features AI-powered algorithm for ECG analysis; Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%); Analyzes resting, non-ambulatory 12-lead ECG recordings; Provides a binary output (Low LVEF Detected / Not Detected); Aids in identifying patients 40+ years at risk of heart failure; Trained on a large dataset of over 930,000 ECGs from 170,000+ patients; Intended for use in clinical diagnostic settings at healthcare facilities AI-automated coronary lumen and wall segmentation; Comprehensive coronary plaque analysis (calcified, non-calcified, low-attenuation); Advanced CMR automation (T1 mapping, 4D flow pre-processing); Vascular CT analysis and planning tools; Automated detection of suspected coronary lesions; Pericoronary Adipose Tissue (PCAT) analysis (research use only); 3D visualization and image fusion; Automated contouring of regions of interest
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Cardiothoracic Surgery, Radiology

Videos

Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and CVI42.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tempus ECG-Low EF analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. CVI42 is an AI-enabled software platform for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools.
Tempus ECG-Low EF provides a binary output (Low LVEF Detected / Not Detected) to aid clinicians in further evaluation for heart failure risk. CVI42 offers advanced analysis, including AI-automated coronary lumen and wall segmentation, comprehensive coronary plaque analysis, and 3D visualization, to enhance diagnosis and planning.
Tempus ECG-Low EF is intended for Cardiology, Emergency Medicine, and Internal Medicine, focusing on early LVEF detection. CVI42 targets Cardiology, Cardiothoracic Surgery, and Radiology, offering comprehensive imaging analysis across CT and MR service lines.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.